Last update 16 Mar 2026

KL0011034

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
KL0011034注射液, KL0011034
Target-
Action-
Mechanism-
Therapeutic Areas
Other Diseases
Active Indication
AnesthesiaSedation
Inactive Indication-
Originator Organization
Sichuan Kelun Pharmaceutical Co., Ltd.Sichuan Kelun Pharmaceutical Co., Ltd.Hunan Kelun Pharmaceutical Co., Ltd.Hunan Kelun Pharmaceutical Co., Ltd.
Active Organization
Hunan Kelun Pharmaceutical Co., Ltd.Hunan Kelun Pharmaceutical Co., Ltd.Sichuan Kelun Pharmacy Institute Co., Ltd.Sichuan Kelun Pharmacy Institute Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with KL0011034
NCT07474545
/ Not yet recruitingPhase 1
A Single-center, Randomized, Double-blind, Placebo-Controlled,Positive-Controlled, Dose-Escalation, Phase 1 Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of a Single Dose Injection of KL0011034 Injection in Healthy Chinese Volunteers
CTR20260622
/ Not yet recruitingPhase 1
一项在健康受试者中评价单次给予KL0011034注射液后的安全性、耐受性和药代动力学特征的单中心、随机、双盲、安慰剂对照、阳性药物对照、剂量递增、I期临床研究
[Translation] A single-center, randomized, double-blind, placebo-controlled, active-drug-controlled, dose-escalation phase I clinical study evaluating the safety, tolerability, and pharmacokinetic characteristics of a single dose of KL0011034 injection in healthy subjects.
100 Clinical Results associated with KL0011034
Login to view more data
100 Translational Medicine associated with KL0011034
Login to view more data
100 Patents (Medical) associated with KL0011034
Login to view more data
100 Deals associated with KL0011034
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AnesthesiaPhase 1
China
Hunan Kelun Pharmaceutical Co., Ltd.Hunan Kelun Pharmaceutical Co., Ltd.
02 Mar 2026
AnesthesiaPhase 1
China
Sichuan Kelun Pharmacy Institute Co., Ltd.Sichuan Kelun Pharmacy Institute Co., Ltd.
02 Mar 2026
SedationPhase 1
China
Sichuan Kelun Pharmacy Institute Co., Ltd.Sichuan Kelun Pharmacy Institute Co., Ltd.
02 Mar 2026
SedationPhase 1
China
Hunan Kelun Pharmaceutical Co., Ltd.Hunan Kelun Pharmaceutical Co., Ltd.
02 Mar 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free